Leveraging the Conamax system to Open New Markets for Therapeutic Monoclonal Antibodies
Time: 4:00 pm
day: Conference Day Two
Details:
- Critical quality attributes required of therapeutic monoclonal antibodies
- Challenges in meeting these requirements when producing mAbs in microbial systems
- Strategies for improving N-glycan occupancy and humanizing N-glycan structures in a novel microbial host for mAb expression
